Please note: Pharmacies are required to report Gabapentin to the Prescription Monitoring Program on August 1, 2017.
Additional details are outlined in the Circular Letter regarding presentation of Customer ID at pick-up, and NPI requirements.
The Data Submission Dispenser Guide has also been updated.
FDA Recall Notice (5/25/17) RE: Lupin Pharmaceuticals Inc. Announces a Nationwide Recall of Mibelas™ 24 Fe (Norethindrone Acetate and EthinylEstradiol 1mg/0.02 mg Chewable Tablets and Ferrous Fumarate 75mg) Tablets Due to Out of Sequence Tablets and Missing Expiry/Lot Information
FDA Recall Notice Re: Mylan (3/31/17) recalls certain lots of EpiPen and EpiPen Jr https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm550170.htm
Recall Notice (2/6/17): Vancomycin compounded products (SCA Pharmaceuticals) file size 1MB file size 1MB
The Massachusetts Prescription Awareness Tool (MassPAT), our new Online Prescription Monitoring Program (PMP), is now live! For more information, including how to register and access MassPAT, please follow this link to the PMP website: www.mass.gov/dph/dcp/pmp.
Important information regarding new MA driver's licenses and IDs
New Pharmacist Continuing Education (CE) Requirements
As of January 1, 2015, CE requirements have changed for all pharmacists registered in Massachusetts. Pharmacists are now required to complete twenty (20) CE hours per calendar year.
Please see the following attachments for more detailed information regarding pharmacist CE requirements.
- Information on mission, activity, membership, calendar, agenda and emergency and holiday closures.
- Includes applications and forms.